• 1
    Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels. J Hypertens 2006; 24: 413422.
  • 2
    Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 1995; 25: 305313.
  • 3
    O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007; 50: 113.
  • 4
    Nichols WW, O'Rourke MF. In: McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles, 5th edn. London: Arnold, 2005.
  • 5
    Dao HH, Essalihi R, Bouvet C, Moreau P. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res 2005; 66: 307317.
  • 6
    McEniery CM, Qasem A, Schmitt M, Avolio AP, Cockcroft JR, Wilkinson IB. Endothelin-1 regulates arterial pulse wave velocity in vivo. J Am Coll Cardiol 2003; 42: 19751981.
  • 7
    Vaitkevicius PV, Fleg JL, Engel JH, O'Connor FC, Wright JG, Lakatta LE, Yin FC, Lakatta EG. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993; 88: 14561462.
  • 8
    Kelly R, Hayward C, Avolio A, O'Rourke M. Non-invasive determination of age-related changes in the human arterial pulse. Circulation 1989; 80: 16521659.
  • 9
    Messerli FH, Sundgaard-Riise K, Ventura HO, Dunn FG, Glade LB, Frohlich ED. Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity and circulating catecholamine levels. Lancet 1983; 2: 983986.
  • 10
    Fleg JL. Effects of aging on the cardiovascular system. In: Adult Clinical Cardiology Self-Assessment Program (ACCSAP 6), ed. Lewis RP . Bethesda, MD: American College of Cardiology Foundation, 2005; 620.
  • 11
    Kario K, Eguchi K, Hoshide S, Hoshide Y, Umeda Y, Mitsuhashi T, Shimada K. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: orthostatic hypertension as a new cardiovascular risk factor. J Am Coll Cardiol 2002; 40: 133141.
  • 12
    Fleg JL, Tzankoff SP, Lakatta EG. Age-related augmentation of plasma catecholamines during dynamic exercise in healthy males. J Appl Physiol 1985; 59: 10331039.
  • 13
    Beck LH. The aging kidney: defending a delicate balance of fluid and electrolytes. Geriatrics 2000; 55: 2628, 31–2.
  • 14
    Fliser D, Ritz E. Relationship between hypertension and renal function and its therapeutic implications in the elderly. Gerontology 1998; 44: 123131.
  • 15
    Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, Ferdinand KC, Ann Forciea M, Frishman WH, Jaigobin C, Kostis JB, Mancia G, Oparil S, Ortiz E, Reisin E, Rich MW, Schocken DD, Weber MA, Wesley DJ, Harrington RA, Bates ER, Bhatt DL, Bridges CR, Eisenberg MJ, Ferrari VA, Fisher JD, Gardner TJ, Gentile F, Gilson MF, Hlatky MA, Jacobs AK, Kaul S, Moliterno DJ, Mukherjee D, Rosenson RS, Stein JH, Weitz HH, Wesley DJ. ACCA/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2011; 57: 20372114.
  • 16
    Masaki KH, Schatz IJ, Burchfiel CM, Sharp DS, Chiu D, Foley D, Curb JD. Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation 1998; 98: 22902295.
  • 17
    Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967; 202: 10281034.
  • 18
    Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program: I. Reduction in Mortality of Persons With High Blood Pressure, Including Mild Hypertension. JAMA 1979; 242: 25622571.
  • 19
    Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program: II. Mortality by race-sex and age. JAMA 1979; 242: 25722577.
  • 20
    Amery A, Brixko P, Clement D, De Schaepdryver A, Fagard R, Forte J, Henry JF, Leonetti G, O'Malley K, Strasser T, Birkenhäger W, Bulpitt C, Deruyttere M, Dollery C, Forette F, Hamdy R, Joossens JV, Lund-Johansen P, Petrie J, Tuomilehto J, Williams B. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1: 13491354.
  • 21
    SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 32553264.
  • 22
    MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405412.
  • 23
    The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757764.
  • 24
    Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 13471351.
  • 25
    Pahor M, Somes GW, Franse LV, Shorr RI, Applegate WB. Prevention of dementia: Syst-Eur trial. Lancet 1999; 353: 235.
  • 26
    Zuccalà G, Pedone C, Cocchi A, Bernabei R, Carbonin P. Prevention of dementia: Syst-Eur trial. Lancet 1999; 353: 235236.
  • 27
    Leys D, Pasquier F. Prevention of dementia: Syst-Eur trial. Lancet 1999; 353: 236237.
  • 28
    Hypertension in the Very Elderly Trial Working Group. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 2003; 21: 24092417.
  • 29
    HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 18871898.
  • 30
    Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 12811285.
  • 31
    Douma S, Petidis K, Zamboulis C. Treatment of Hypertension in the Elderly. N Engl J Med 2008; 359: 971972.
  • 32
    Messerli FH, Sulicka J, Gryglewska B. Treatment of Hypertension in the Elderly. N Engl J Med 2008; 359: 972973.
  • 33
    Denardo SJ, Gong Y, Wilmer WN, Messerli FH, Bavry AA, Cooper-Dehoff RM, Handberg EM, Champion A, Pepine CJ. Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: an INVEST Substudy. Am J Med 2010; 123: 719726.
  • 34
    Fletcher A, Amery A, Birkenhäger W, Bulpitt C, Clement D, de Leeuw P, Deruyterre ML, de Schaepdryver A, Dollery C, Fagard R, Forette F, Forte J, Henry J, Koistinen A, Leonetti G, Lnnd-Johansen P, Nissinen A, O'Brien F, O'Malley K, Pelemans W, Petrie J, Staessen J, Terzoli L, Thijs L, Tuomilehto J, Webster J, Williams B. Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly. J Hypertens 1991; 9: 225230.
  • 35
    Fletcher AE. Adverse treatment effects in the trial of the European Working Party on High Blood Pressure in the Elderly. Am J Med 1991; 90: (3A): 42S44.
  • 36
    Duggan S, Ford GA, Eccles M. Doctors’ attitudes towards the detection and treatment of hypertension in older people. J Hum Hypertens 1997; 11: 271276.
  • 37
    Dusing R, Weisser B, Mengden T, Vetter H. Changes in antihypertensive therapy: the role of adverse effects and compliance. Blood Press 1998; 7: 313315.
  • 38
    Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 19031913.